Rob Knight, PhD
Leadership Team
1) Dwayne Roach, PhD - March 27, 2019, at UCSD
2) Chip Schooley, MD - April 24, 2019, at SDSU
3) Graham Hatful, PhD - May 29, 2019, at UCSD
4) David Pride, MD PhD - June 26, 2019, at SDSU
5) Katrine Whiteson, PhD - August 28, 2019, at SDSU
6) Vincent Fischetti, PhD - September 25, 2019, at UCSD
7) Justin Meyer, PhD - October 23, 2019, at SDSU
8) Forest Rohwer, PhD - November 20, 2019, at UCSD
9) Paul Bollyky, PhD - January 29, 2020, at SDSU
10) Rob Edwards, PhD - February 26, 2020, at UCSD
11) Kimberly Seed, PhD - April 22, 2020, at UCSD
12) June Round, PhD - June 24, 2020, at UCSD
Leadership Team
Hedieh Attai, PhD
Postdoctoral Scholar
Connie Benson, MD
Leadership Team
Chip Schooley, MD
Co-Director
The Center for Innovative Phage Applications and Therapeutics (IPATH) was founded in the UC San Diego School of Medicine in June 2018 with seed funding from UC San Diego Chancellor Pradeep Khosla. Our goal is to pursue, through collaboration with researchers, companies and institutions around the world, new treatments for combating antimicrobial resistant diseases—focusing on bacteriophage (phage) therapy. We have treated and will continue to treat patients with life-threatening multi-drug resistant infections with phage therapy through the FDA’s compassionate use program. We also strive to advance phage therapy into clinical trials so that it can be rigorously evaluated and if proven efficacious, become more widely available to combat the global superbug crisis.
Dwayne Roach, PhD
Affiliate Member
Research Team
David Pride, MD PhD
Leadership Team
Translational Research In Bacteriophage Therapies Seminar Series
Katrine Whiteson, PhD
Affiliate Member
Lina Huang, BS
Research Associate
Steffanie Strathdee, PhD
Co-Director
Saima Aslam, MD
Leadership Team